drug · antibody
romosozumab
Phase 3updated 3mo agoby $AMGN AMGEN INC🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 2Antibody drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 2 investigational indications.
targets
Sclerostin
all catalysts(0)
nothing on the calendar yet
Trials studying romosozumab
- phase2Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
- phase3Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
- phase2Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes
- phase2Romosozumab/Denosumab Study for Premenopausal IOP
- phase1Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects
- phase3Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa
- phase4A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.
- phase2Romosozumab in Women With Chronic SCI
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that